世界の乾癬治療薬市場分析・成長予測(~2030):種類別、作用機序別、投与経路別

◆英語タイトル:Psoriasis Drugs Market Research Report: By Type, Mechanism of Action, Route of Administration - Global Industry Analysis and Demand Forecast to 2030

P&S Market Researchが発行した調査報告書(PS21JN025)◆商品コード:PS21JN025
◆発行会社(リサーチ会社):P&S Market Research
◆発行日:2021年3月
◆ページ数:n/a
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD4,185 ⇒換算¥619,380見積依頼/購入/質問フォーム
5 UserUSD5,466 ⇒換算¥808,968見積依頼/購入/質問フォーム
Enterprise UserUSD7,174 ⇒換算¥1,061,752見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

In 2020, 125 million people around the world had psoriasis, compared to 100 million in 2016, as per the National Psoriasis Foundation. On account of the rising number of people suffering from this skin condition, the global psoriasis drugs market size will likely grow to $53,210.6 million by 2030 from $14,504.0 million in 2020, at a 14.0% CAGR between 2021 and 2030, according to the market research report.
A wide range of conditions and diseases can result in psoriasis, including strep throat, cold, dry weather, cuts, scrapes, bug bites, severe sunburn, stress, smoking and exposure to second-hand smoke, family history of psoriasis, and heavy alcohol consumption. Another key driver for the psoriasis drugs market is the booming geriatric population, since the disease is most common in the elderly.

The impact of COVID-19 on the psoriasis drugs market has been negative on account of the shutting down of cosmetic clinics and dermatology departments of hospitals during the initial period. Moreover, financial distress forced people to only spend on essential stuff, including food and important healthcare services. However, the launch of several drugs for the disease recently helped the market recover to a significant extent.

The biologic drugs category is expected to witness the fastest growth in the psoriasis drugs market in the coming years, based on type. With the increasing knowledge of the immunopathogenesis and genetics associated with the diseases, better biologic drugs are being created, which not only treat psoriasis but also lower the risk of its comorbidities, including inflammatory bowel disease (IBD), psoriatic arthritis (PsA), and cancers.

In the past, the psoriasis drugs market was dominated by the interleukin inhibitors category, on the basis of mechanism of action (MoA). On account of the rising prevalence of this disease and autoimmune conditions, the demand for interleukin inhibitors is increasing. These drugs reduce the degree of the immune response, by targeting immune signaling molecules, or cytokines, which prevents the occurrence of psoriasis.

In the years to come, the highest CAGR in the psoriasis drugs market is predicted to be seen in the Asia-Pacific (APAC) region. With the rising disposable income of the people in regional countries, they are spending more freely on skincare than ever before. Moreover, the region is home to the largest geriatric population in the world, which results in a high prevalence of psoriasis.

Major companies in the global psoriasis drugs market are Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Johnson & Johnson, AbbVie Inc., Merck & Co. Inc., Eli Lilly and Company, Mylan N.V., GlaxoSmithKline plc, Bausch Health Companies Inc., Galderma S.A., Amgen Inc., and LEO Pharma A/S.

❖ レポートの目次 ❖

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.4.1 Value
1.5 Market Size Breakdown by Segment
1.5.1 Market Segmentation by Type
1.5.2 Market Segmentation by Mechanism of Action (MoA)
1.5.3 Market Segmentation by Route of Administration (RoA)
1.5.4 Market Segmentation by Region
1.6 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 Publisher Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Region
2.2.2 Breakdown of Primary Research, by Industry Participant
2.2.3 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators
5.1 Dermatology Drugs Market – The Parent Market

Chapter 6. Definition of Market Segments
6.1 By Type
6.1.1 Biologic Drugs
6.1.2 Small-Molecule Systemic Drugs
6.1.3 Topical Therapies
6.2 By MoA
6.2.1 TNF-Alpha Inhibitors
6.2.2 PDE4 Inhibitors
6.2.3 Interleukin Inhibitors
6.2.4 Others
6.3 By RoA
6.3.1 Oral
6.3.2 Parenteral
6.3.3 Topical

Chapter 7. Industry Outlook
7.1 Market Dynamics
7.1.1 Trends
7.1.1.1 Increasing number of product approvals
7.1.2 Drivers
7.1.2.1 Rising geriatric population
7.1.2.2 Increasing prevalence of psoriasis
7.1.2.3 Growing awareness about psoriasis
7.1.2.4 Extensive pipeline of psoriasis drugs
7.1.2.5 Impact analysis of drivers on market forecast
7.1.3 Restraints
7.1.3.1 Patent expiry of some popular drugs
7.1.3.2 Side-effects of certain classes of therapeutic drugs
7.1.3.3 Impact analysis of restraints on market forecast
7.1.4 Opportunities
7.1.4.1 Huge potential in emerging markets
7.2 Impact of COVID-19
7.2.1 Porter’s Five Forces Analysis

Chapter 8. Global Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Type (2015-2030)
8.3 Market Revenue, by MoA (2015-2030)
8.4 Market Revenue, by RoA (2015-2030)
8.5 Market Revenue, by Region (2015-2030)

Chapter 9. North America Market Size and Forecast
9.1 Overview
9.2 Market Revenue, by Type (2015-2030)
9.3 Market Revenue, by MoA (2015-2030)
9.4 Market Revenue, by RoA (2015-2030)
9.5 Market Revenue, by Country (2015-2030)

Chapter 10. Europe Market Size and Forecast
10.1 Overview
10.2 Market Revenue, by Type (2015-2030)
10.3 Market Revenue, by MoA (2015-2030)
10.4 Market Revenue, by RoA (2015-2030)
10.5 Market Revenue, by Country (2015-2030)

Chapter 11. APAC Market Size and Forecast
11.1 Overview
11.2 Market Revenue, by Type (2015-2030)
11.3 Market Revenue, by MoA (2015-2030)
11.4 Market Revenue, by RoA (2015-2030)
11.5 Market Revenue, by Country (2015-2030)

Chapter 12. LATAM Market Size and Forecast
12.1 Overview
12.2 Market Revenue, by Type (2015-2030)
12.3 Market Revenue, by MoA (2015-2030)
12.4 Market Revenue, by RoA (2015-2030)
12.5 Market Revenue, by Country (2015-2030)

Chapter 13. MEA Market Size and Forecast
13.1 Overview
13.2 Market Revenue, by Type (2015-2030)
13.3 Market Revenue, by MoA (2015-2030)
13.4 Market Revenue, by RoA (2015-2030)
13.5 Market Revenue, by Country (2015-2030)

Chapter 14. U.S. Market Size and Forecast
14.1 Overview
14.2 Market Revenue, by Type (2015-2030)
14.3 Market Revenue, by MoA (2015-2030)
14.4 Market Revenue, by RoA (2015-2030)

Chapter 15. Canada Market Size and Forecast
15.1 Overview
15.2 Market Revenue, by Type (2015-2030)
15.3 Market Revenue, by MoA (2015-2030)
15.4 Market Revenue, by RoA (2015-2030)

Chapter 16. Germany Market Size and Forecast
16.1 Overview
16.2 Market Revenue, by Type (2015-2030)
16.3 Market Revenue, by MoA (2015-2030)
16.4 Market Revenue, by RoA (2015-2030)

Chapter 17. France Market Size and Forecast
17.1 Overview
17.2 Market Revenue, by Type (2015-2030)
17.3 Market Revenue, by MoA (2015-2030)
17.4 Market Revenue, by RoA (2015-2030)

Chapter 18. U.K. Market Size and Forecast
18.1 Overview
18.2 Market Revenue, by Type (2015-2030)
18.3 Market Revenue, by MoA (2015-2030)
18.4 Market Revenue, by RoA (2015-2030)

Chapter 19. Italy Market Size and Forecast
19.1 Overview
19.2 Market Revenue, by Type (2015-2030)
19.3 Market Revenue, by MoA (2015-2030)
19.4 Market Revenue, by RoA (2015-2030)

Chapter 20. Spain Market Size and Forecast
20.1 Overview
20.2 Market Revenue, by Type (2015-2030)
20.3 Market Revenue, by MoA (2015-2030)
20.4 Market Revenue, by RoA (2015-2030)

Chapter 21. Japan Market Size and Forecast
21.1 Overview
21.2 Market Revenue, by Type (2015-2030)
21.3 Market Revenue, by MoA (2015-2030)
21.4 Market Revenue, by RoA (2015-2030)

Chapter 22. China Market Size and Forecast
22.1 Overview
22.2 Market Revenue, by Type (2015-2030)
22.3 Market Revenue, by MoA (2015-2030)
22.4 Market Revenue, by RoA (2015-2030)

Chapter 23. India Market Size and Forecast
23.1 Overview
23.2 Market Revenue, by Type (2015-2030)
23.3 Market Revenue, by MoA (2015-2030)
23.4 Market Revenue, by RoA (2015-2030)

Chapter 24. Australia Market Size and Forecast
24.1 Overview
24.2 Market Revenue, by Type (2015-2030)
24.3 Market Revenue, by MoA (2015-2030)
24.4 Market Revenue, by RoA (2015-2030)

Chapter 25. South Korea Market Size and Forecast
25.1 Overview
25.2 Market Revenue, by Type (2015-2030)
25.3 Market Revenue, by MoA (2015-2030)
25.4 Market Revenue, by RoA (2015-2030)

Chapter 26. Brazil Market Size and Forecast
26.1 Overview
26.2 Market Revenue, by Type (2015-2030)
26.3 Market Revenue, by MoA (2015-2030)
26.4 Market Revenue, by RoA (2015-2030)

Chapter 27. Mexico Market Size and Forecast
27.1 Overview
27.2 Market Revenue, by Type (2015-2030)
27.3 Market Revenue, by MoA (2015-2030)
27.4 Market Revenue, by RoA (2015-2030)

Chapter 28. Saudi Arabia Market Size and Forecast
28.1 Overview
28.2 Market Revenue, by Type (2015-2030)
28.3 Market Revenue, by MoA (2015-2030)
28.4 Market Revenue, by RoA (2015-2030)

Chapter 29. South Africa Market Size and Forecast
29.1 Overview
29.2 Market Revenue, by Type (2015-2030)
29.3 Market Revenue, by MoA (2015-2030)
29.4 Market Revenue, by RoA (2015-2030)

Chapter 30. Competitive Landscape
30.1 List of Major Drugs and Their Manufacturers
30.2 Recent Strategic Developments of Key Players
30.2.1 Product Launches and Approvals
30.2.2 Acquisitions
30.2.3 Other Developments

Chapter 31. Company Profiles
31.1 Novartis AG
31.1.1 Business Overview
31.1.2 Product and Service Offerings
31.1.3 Key Financial Summary
31.2 Pfizer Inc.
31.2.1 Business Overview
31.2.2 Product and Service Offerings
31.2.3 Key Financial Summary
31.3 Bristol-Myers Squibb Company
31.3.1 Business Overview
31.3.2 Product and Service Offerings
31.3.3 Key Financial Summary
31.4 Johnson & Johnson
31.4.1 Business Overview
31.4.2 Product and Service Offerings
31.4.3 Key Financial Summary
31.5 Merck & Co. Inc.
31.5.1 Business Overview
31.5.2 Product and Service Offerings
31.5.3 Key Financial Summary
31.6 AbbVie Inc.
31.6.1 Business Overview
31.6.2 Product and Service Offerings
31.6.3 Key Financial Summary
31.7 Eli Lilly and Company
31.7.1 Business Overview
31.7.2 Product and Service Offerings
31.7.3 Key Financial Summary
31.8 GlaxoSmithKline plc
31.8.1 Business Overview
31.8.2 Product and Service Offerings
31.8.3 Key Financial Summary
31.9 Mylan N.V.
31.9.1 Business Overview
31.9.2 Product and Service Offerings
31.9.3 Key Financial Summary
31.10 Bausch Health Companies Inc.
31.10.1 Business Overview
31.10.2 Product and Service Offerings
31.10.3 Key Financial Summary
31.11 Amgen Inc.
31.11.1 Business Overview
31.11.2 Product and Service Offerings
31.11.3 Key Financial Summary
31.12 Galderma S.A.
31.12.1 Business Overview
31.12.2 Product and Service Offerings
31.13 LEO Pharma A/S
31.13.1 Business Overview
31.13.2 Product and Service Offerings
31.13.3 Key Financial Summary

Chapter 32. Appendix
32.1 Abbreviations
32.2 Sources and References
32.3 Related Reports

List of Tables
Table 1 Analysis Period of The Study
Table 2 List of Major Pipeline Drugs For Psoriasis
Table 3 Drivers For The Market: Impact Analysis
Table 4 Patent Expiration of Psoriasis Drugs
Table 5 Restraints For The Market: Impact Analysis
Table 6 Global Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 7 Global Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 8 Global Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 9 Global Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 10 Global Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 11 Global Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 12 Global Psoriasis Drugs Market Revenue, By Region, $M (2015-2020)
Table 13 Global Psoriasis Drugs Market Revenue, By Region, $M (2021-2030)
Table 14 North America Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 15 North America Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 16 North America Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 17 North America Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 18 North America Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 19 North America Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 20 North America Psoriasis Drugs Market Revenue, By Country, $M (2015-2020)
Table 21 North America Psoriasis Drugs Market Revenue, By Country, $M (2021-2030)
Table 22 Europe Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 23 Europe Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 24 Europe Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 25 Europe Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 26 Europe Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 27 Europe Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 28 Europe Psoriasis Drugs Market Revenue, By Country, $M (2015-2020)
Table 29 Europe Psoriasis Drugs Market Revenue, By Country, $M (2021-2030)
Table 30 Apac Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 31 Apac Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 32 Apac Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 33 Apac Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 34 Apac Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 35 Apac Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 36 Apac Psoriasis Drugs Market Revenue, By Country, $M (2015-2020)
Table 37 Apac Psoriasis Drugs Market Revenue, By Country, $M (2021-2030)
Table 38 Latam Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 39 Latam Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 40 Latam Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 41 Latam Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 42 Latam Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 43 Latam Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 44 Latam Psoriasis Drugs Market Revenue, By Country, $M (2015-2020)
Table 45 Latam Psoriasis Drugs Market Revenue, By Country, $M (2021-2030)
Table 46 Mea Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 47 Mea Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 48 Mea Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 49 Mea Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 50 Mea Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 51 Mea Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 52 Mea Psoriasis Drugs Market Revenue, By Country, $M (2015-2020)
Table 53 Mea Psoriasis Drugs Market Revenue, By Country, $M (2021-2030)
Table 54 U.S. Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 55 U.S. Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 56 U.S. Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 57 U.S. Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 58 U.S. Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 59 U.S. Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 60 Canada Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 61 Canada Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 62 Canada Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 63 Canada Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 64 Canada Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 65 Canada Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 66 Germany Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 67 Germany Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 68 Germany Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 69 Germany Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 70 Germany Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 71 Germany Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 72 France Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 73 France Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 74 France Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 75 France Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 76 France Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 77 France Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 78 U.K. Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 79 U.K. Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 80 U.K. Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 81 U.K. Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 82 U.K. Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 83 U.K. Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 84 Italy Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 85 Italy Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 86 Italy Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 87 Italy Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 88 Italy Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 89 Italy Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 90 Spain Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 91 Spain Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 92 Spain Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 93 Spain Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 94 Spain Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 95 Spain Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 96 Japan Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 97 Japan Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 98 Japan Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 99 Japan Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 100 Japan Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 101 Japan Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 102 China Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 103 China Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 104 China Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 105 China Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 106 China Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 107 China Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 108 India Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 109 India Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 110 India Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 111 India Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 112 India Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 113 India Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 114 Australia Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 115 Australia Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 116 Australia Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 117 Australia Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 118 Australia Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 119 Australia Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 120 South Korea Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 121 South Korea Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 122 South Korea Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 123 South Korea Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 124 South Korea Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 125 South Korea Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 126 Brazil Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 127 Brazil Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 128 Brazil Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 129 Brazil Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 130 Brazil Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 131 Brazil Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 132 Mexico Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 133 Mexico Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 134 Mexico Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 135 Mexico Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 136 Mexico Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 137 Mexico Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 138 Saudi Arabia Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 139 Saudi Arabia Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 140 Saudi Arabia Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 141 Saudi Arabia Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 142 Saudi Arabia Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 143 Saudi Arabia Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 144 South Africa Psoriasis Drugs Market Revenue, By Type, $M (2015-2020)
Table 145 South Africa Psoriasis Drugs Market Revenue, By Type, $M (2021-2030)
Table 146 South Africa Psoriasis Drugs Market Revenue, By Moa, $M (2015-2020)
Table 147 South Africa Psoriasis Drugs Market Revenue, By Moa, $M (2021-2030)
Table 148 South Africa Psoriasis Drugs Market Revenue, By Roa, $M (2015-2020)
Table 149 South Africa Psoriasis Drugs Market Revenue, By Roa, $M (2021-2030)
Table 150 List of Major Drugs And Their Manufacturers
Table 151 Novartis Ag – At A Glance
Table 152 Novartis Ag – Key Financial Summary
Table 153 Pfizer Inc. – At A Glance
Table 154 Pfizer Inc. – Key Financial Summary
Table 155 Bristol-Myers Squibb Company – At A Glance
Table 156 Bristol-Myers Squibb Company – Key Financial Summary
Table 157 Johnson & Johnson – At A Glance
Table 158 Johnson & Johnson – Key Financial Summary
Table 159 Merck & Co. Inc. – At A Glance
Table 160 Merck & Co. Inc. – Key Financial Summary
Table 161 Abbvie Inc. – At A Glance
Table 162 Abbvie Inc. – Key Financial Summary
Table 163 Eli Lilly And Company – At A Glance
Table 164 Eli Lilly And Company – Key Financial Summary
Table 165 Glaxosmithkline Plc – At A Glance
Table 166 Glaxosmithkline Plc – Key Financial Summary
Table 167 Mylan N.V. – At A Glance
Table 168 Mylan N.V. – Key Financial Summary
Table 169 Bausch Health Companies Inc. – At A Glance
Table 170 Bausch Health Companies Inc. – Key Financial Summary
Table 171 Amgen Inc. – At A Glance
Table 172 Amgen Inc. – Key Financial Summary
Table 173 Galderma S.A. – At A Glance
Table 174 Leo Pharma A/S – At A Glance
Table 175 Leo Pharma A/S – Key Financial Summary

List of Figures
Fig 1 Market Size Breakdown By Segment
Fig 2 Research Methodology
Fig 3 Breakdown of Primary Research, By Region
Fig 4 Breakdown of Primary Research, By Industry Participant
Fig 5 Breakdown of Primary Research, By Company Type
Fig 6 Data Triangulation Approach
Fig 7 Currency Conversion Rates For Usd (2020)
Fig 8 Global Psoriasis Drugs Market Summary
Fig 9 Voice of Industry Experts/Kols
Fig 10 Bargaining Power of Buyers
Fig 11 Bargaining Power of Suppliers
Fig 12 Intensity of Rivalry
Fig 13 Threat of New Entrants
Fig 14 Threat of Substitutes
Fig 15 Global Psoriasis Drugs Market Snapshot
Fig 16 Global Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 17 Global Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 18 Global Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 19 Global Psoriasis Drugs Market Revenue, By Region, $M (2015-2030)
Fig 20 North America Psoriasis Drugs Market Snapshot
Fig 21 North America Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 22 North America Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 23 North America Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 24 North America Psoriasis Drugs Market Revenue, By Country, $M (2015-2030)
Fig 25 Europe Psoriasis Drugs Market Snapshot
Fig 26 Europe Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 27 Europe Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 28 Europe Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 29 Europe Psoriasis Drugs Market Revenue, By Country, $M (2015-2030)
Fig 30 Apac Psoriasis Drugs Market Snapshot
Fig 31 Apac Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 32 Apac Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 33 Apac Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 34 Apac Psoriasis Drugs Market Revenue, By Country, $M (2015-2030)
Fig 35 Latam Psoriasis Drugs Market Snapshot
Fig 36 Latam Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 37 Latam Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 38 Latam Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 39 Latam Psoriasis Drugs Market Revenue, By Country, $M (2015-2030)
Fig 40 Mea Psoriasis Drugs Market Snapshot
Fig 41 Mea Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 42 Mea Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 43 Mea Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 44 Mea Psoriasis Drugs Market Revenue, By Country, $M (2015-2030)
Fig 45 U.S. Psoriasis Drugs Market Snapshot
Fig 46 U.S. Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 47 U.S. Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 48 U.S. Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 49 Canada Psoriasis Drugs Market Snapshot
Fig 50 Canada Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 51 Canada Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 52 Canada Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 53 Germany Psoriasis Drugs Market Snapshot
Fig 54 Germany Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 55 Germany Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 56 Germany Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 57 France Psoriasis Drugs Market Snapshot
Fig 58 France Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 59 France Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 60 France Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 61 U.K. Psoriasis Drugs Market Snapshot
Fig 62 U.K. Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 63 U.K. Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 64 U.K. Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 65 Italy Psoriasis Drugs Market Snapshot
Fig 66 Italy Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 67 Italy Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 68 Italy Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 69 Spain Psoriasis Drugs Market Snapshot
Fig 70 Spain Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 71 Spain Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 72 Spain Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 73 Japan Psoriasis Drugs Market Snapshot
Fig 74 Japan Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 75 Japan Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 76 Japan Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 77 China Psoriasis Drugs Market Snapshot
Fig 78 China Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 79 China Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 80 China Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 81 India Psoriasis Drugs Market Snapshot
Fig 82 India Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 83 India Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 84 India Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 85 Australia Psoriasis Drugs Market Snapshot
Fig 86 Australia Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 87 Australia Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 88 Australia Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 89 South Korea Psoriasis Drugs Market Snapshot
Fig 90 South Korea Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 91 South Korea Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 92 South Korea Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 93 Brazil Psoriasis Drugs Market Snapshot
Fig 94 Brazil Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 95 Brazil Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 96 Brazil Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 97 Mexico Psoriasis Drugs Market Snapshot
Fig 98 Mexico Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 99 Mexico Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 100 Mexico Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 101 Saudi Arabia Psoriasis Drugs Market Snapshot
Fig 102 Saudi Arabia Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 103 Saudi Arabia Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 104 Saudi Arabia Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 105 South Africa Psoriasis Drugs Market Snapshot
Fig 106 South Africa Psoriasis Drugs Market Revenue, By Type, $M (2015-2030)
Fig 107 South Africa Psoriasis Drugs Market Revenue, By Moa, $M (2015-2030)
Fig 108 South Africa Psoriasis Drugs Market Revenue, By Roa, $M (2015-2030)
Fig 109 Novartis Ag – Revenue Split By Segment And Geography (2020)
Fig 110 Pfizer Inc. – Revenue Split By Segment And Geography (2020)
Fig 111 Bristol-Myers Squibb Company – Revenue Split By Segment And Geography (2020)
Fig 112 Johnson & Johnson – Revenue Split By Segment And Geography (2020)
Fig 113 Merck & Co. Inc. – Revenue Split By Segment And Geography (2020)
Fig 114 Abbvie Inc. – Revenue Split By Product Category And Geography (2020)
Fig 115 Eli Lilly And Company – Revenue Split By Therapeutic Area And Geography (2020)
Fig 116 Glaxosmithkline Plc – Revenue Split By Segment And Geography (2020)
Fig 117 Mylan N.V. – Revenue Split By Therapeutic Area And Geography (2019)
Fig 118 Bausch Health Companies Inc. – Revenue Split By Segment And Geography (2020)
Fig 119 Amgen Inc. – Revenue Split By Product And Geography (2020)
Fig 120 Leo Pharma A/S – Revenue Split By Therapeutic Area And Geography (2020)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の乾癬治療薬市場分析・成長予測(~2030):種類別、作用機序別、投与経路別(Psoriasis Drugs Market Research Report: By Type, Mechanism of Action, Route of Administration - Global Industry Analysis and Demand Forecast to 2030)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆